Press Releases -> Pharmaceuticals & Biotech Syndicate content

Apr 01, 2020

Modalis Therapeutics and Editas Medicine conclude license

Mar 30, 2020

With biotech offering famously narrow market windows, many manufacturers need to go to great lengths to remain truly competitive.
30 March 2020

Viewed as very much a new frontier, the defining characteristics of the biotechnology sector appear to be the sheer breadth of its potential applications and...

Mar 27, 2020

- Kissei Gains Regional License to CG0070 for Japan, South Korea, Taiwan and Other Asian Countries With the Exception of China -
- Deal Valued at Up to $140 Million Plus Royalties, Including a $10 Million Licensing Fee and $30 Million Equity Investment -

Mar 25, 2020

Opportunities for excipient industry via New & Complex R&D

Mar 24, 2020

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have found a way to turn pollen, one of the hardest materials in the plant kingdom, into a soft and flexible material, with the potential to serve as a ‘building block’ for the design of new categories of eco-friendly materials.


Mar 10, 2020

New study will generate insights in the development and progression of the disease in Asia, which could support the development of effective diagnostics and therapies.

Mar 09, 2020

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that the Company has engaged Torreya Partners,...

Feb 13, 2020

A wave of innovations in IoT, 5G and AI has moved from the lab into the marketplace.

Feb 10, 2020

SUZHOU, China, Feb. 10, 2020 -- Based on publicly available data, a data model on a recently launched website set up by an ad-hoc group of scientists predicts the number of new, confirmed novel coronavirus cases in China to dwindle to almost nothing in under two weeks.

"The current model predicts a rapid...

Jan 31, 2020
  • Novena Global Lifecare (NGL)'s (through its subsidiary Novena Bellagraph Healthcare) donation is the first of its kind from Singapore Company and coincides with the World Health Organisation (WHO) declaration of the Wuhan epidemic as an international emergency.
  • The medical supply donation will benefit...
  • Jan 28, 2020

    Singaporean biotech start-up MiRXES, National University of Singapore (NUS) and Diagnostics Development (DxD) Hub of the Agency for Science, Technology and Research (A*STAR) spearhead three initiatives to position Singapore as a global leader in translating microRNA research into clinical applications that will...

    Jan 28, 2020

    Complete qPCR panel of the CDC-published sequences for coronavirus detection in addition to preferred pricing on gBlocks fragments and synthetic genes ordered for vaccine development

    CORALVILLE, Iowa - Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that it...

    Jan 14, 2020

    Crisdesalazine demonstrated significant improvement in cognition function in the primary outcome measure
    Crisdesalazine demonstrated significant improvement in dementia in the secondary outcome measures

    YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma has successfully completed a Phase III clinical...

    Jan 14, 2020

    ANN ARBOR, Mich. & BEIJING--(BUSINESS WIRE)--Celsee, Inc., a leading provider of single-cell isolation technology, and Kindstar Global, the largest medical esoteric testing service group in China, today announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s...

    Jan 14, 2020

    MIAMI--(BUSINESS WIRE)--Singapore-based precision oncology startup Lucence, on the heels of its series A funding, is sharing early data highlighting the capabilities of its liquid biopsy technology to detect somatic variants in patients with blood cancers, with excellent matching between bone marrow and blood....

    Jan 10, 2020

    GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, today announced that QLETLI® (格乐立®), a biosimilar to Humira® (adalimumab), is now available in China. QLETLI® (格乐立®), the first adalimumab biosimilar approved by the China National Medical Products...

    Jan 08, 2020

    HYDERABAD, India & SAN JOSE, Calif.--(BUSINESS WIRE)--Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world's largest vaccine...

    Jan 02, 2020

    ROCKVILLE, Md.--(BUSINESS WIRE)--On January 2nd, the Psomagen-Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US...

    Dec 16, 2019

    TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi, “Meiji”) and Dong-A Socio Holdings Co., Ltd. (Headquarters: Seoul, Korea, CEO: Jong Hyun Han, “Dong-A”) today announced the initiation of a Phase I clinical trial of DMB-...

    Dec 11, 2019

    TOKYO --( ASIA TODAY )-- Toshiba Corporation (TOKYO: 6502) has developed a simple, highly accurate cancer detection technology that utilizes microRNA(Note 1) in blood. With a unique electrochemical microRNA detection technology, the company confirmed to comprehensively distinguish between healthy individuals and...

    Dec 02, 2019
  • The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB
  • CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project
  • The...
  • Nov 19, 2019

    SHENZHEN, China--(BUSINESS WIRE)--When the creative minds that drive Israeli biotechnology company Matricelf started telling people about their plan to create the world’s first 3D printed human heart the common response was that they were talking about the stuff of dreams.

    But Matricelf’s vision has now...